An illustrative 1970s research laboratory with a typewriter, notebooks and filing cabinets; no people depicted. White text reads WHO WAS DR SINCLAIR?; Rethink Drink stacked logo lower-left.

John David Sinclair: Who Developed The Sinclair Method?

June 11, 2025•11 min read

By Rethink Drink. For UK adults. Reviewed November 2026.

Dr John David Sinclair (born 1943, died 2015) was the American scientist who developed The Sinclair Method.

He spent most of his working life in Finland, at the research laboratories of Alko, the Finnish state alcohol company. His work there led to an idea he called pharmacological extinction: using a medicine to help the brain unlearn its drinking response, while the person is still drinking.

He's often called David Sinclair. And no... he isn't the Harvard ageing scientist of the same name. Different man, different field.

Maybe you've just heard of the method and want to know who's behind it. Or maybe you've already tried AA, a detox, or naltrexone on its own, and you're checking whether this one stands up.

In short

  • Who: Dr John David Sinclair, an American behavioural scientist. Born in the United States in 1943, he moved to Helsinki in 1972 and died in 2015, aged 72.

  • His first big finding: in 1967, as a student, he found that rats kept away from alcohol drank more once it came back. It's called the alcohol deprivation effect.

  • His big idea: drinking is a learned response, rewarded through the brain's opioid system. Block that reward while someone drinks, and the response can fade over time. He patented the idea in 1989.

  • The evidence: naltrexone has a real, moderate effect in controlled trials. The well-known 78% figure comes from an open study in Finland, not a controlled trial. Results vary.

  • In the UK today: The Sinclair Method uses naltrexone, taken before drinking, at a time your prescriber sets. That's off-label in the UK.

  • Check first: if your body depends on alcohol, stopping or cutting down too fast can be dangerous. Speak to your GP (General Practitioner) or local alcohol service before you change anything.

Who was Dr John David Sinclair?

John David Sinclair was born in the United States in 1943.

As a young researcher, he studied alcohol drinking in rats at the University of Cincinnati.

In 1972, soon after finishing his PhD, he moved to Helsinki, to work at Alko's research laboratory. Alko was Finland's state-owned alcohol company, with the monopoly on selling stronger drinks. In the 1990s, the laboratory's biomedical research moved to Finland's National Public Health Institute.

He spent the rest of his career in Finland. He died in April 2015, aged 72.

So the method wasn't born in a clinic or a rehab. It was born in a lab, from years of work on how drinking is learned.

What did Sinclair discover first?

In 1967, while still a student, Sinclair published a study with R J Senter. Rats that had been drinking alcohol were kept away from it for a while.

When it came back... they drank more than before.

It's called the alcohol deprivation effect.

He later summed up what his research had shown in plain words: detoxification and alcohol deprivation "do not stop alcohol craving but in fact increase subsequent alcohol drinking".

If you've ever been sober for weeks or months, had one drink, and found yourself straight back where you left off... that finding might feel familiar. It's one reason that can happen, and weakness isn't one of them.

...More on that in Alcohol relapse.

How did that lead to The Sinclair Method?

If time away from alcohol didn't remove the drive to drink, Sinclair asked a different question.

What if the drive could be unlearned?

His research pointed to the brain's opioid system. When you drink, the brain releases its own feel-good chemicals, endorphins among them. They land on opioid receptors, and that's the reward. Brain scans in 2012 showed this happening in people as they drank (Mitchell and colleagues).

Medicines called opioid blockers, such as naltrexone, sit on those receptors. So the endorphins have almost nowhere to land, which is how the reward cycle is interrupted.

Psychologists already had a word for what happens when a learned behaviour stops being rewarded: extinction. Sinclair's patent put it simply: "Extinction consists of having the response emitted repeatedly in the absence of positive reinforcement."

In other words... the drinking happens, but the reward doesn't arrive. Over time, the brain stops showing up for it. Like a job you're no longer being paid for.

He patented the idea, with Alko as the assignee. It was filed in 1988 and granted in November 1989.

...The science, in plain English: What is pharmacological extinction?

What did his research actually show?

Here it is in order, described as each study really was.

In rats. In his 2001 review, Sinclair summed up years of animal work. Rats that drank alcohol while an opioid blocker was in place "progressively decreased" their drinking.

But giving the same medicines during abstinence, without drinking, "was not useful": it didn't reduce later drinking, and tended to increase it.

That's the heart of the method. The blocker only helps unlearn a response that actually happens while it's in place.

In people. The same review pointed to eight double-blind, placebo-controlled trials of naltrexone in five countries. And Sinclair noticed a pattern in three of them, which compared two kinds of support. In all three, naltrexone beat the dummy pill for people given coping skills therapy. In none of them did it beat the dummy pill for people given general support aimed at abstinence.

One of those was a Finnish trial he co-wrote (Heinälä and colleagues, 2001). It followed 121 people with alcohol dependence who were still drinking at the start, for 32 weeks. In the coping skills groups, 27% of people on naltrexone had no relapse to heavy drinking in that time, against 3% on the dummy pill. In the general support groups, naltrexone didn't beat the dummy pill.

Read that again... Same medicine. Different support. Different result.

In clinics. The same review is where the famous 78% comes from. In an open study in Finland, of 147 patients who had completed enough treatment to be assessed, 115 (78%) were judged successful.

That figure is real... but it isn't the whole picture. It came from an open study, with no dummy-pill group, and people who hadn't completed enough treatment weren't counted.

What controlled trials show today. A Cochrane review of 50 trials, with 7,793 people, found naltrexone reduced the risk of heavy drinking to 83% of the risk on a dummy pill. A real effect. A moderate one. And it varies from person to person.

...We've set out the evidence honestly, including what it can't tell you: What the research really shows.

Did Sinclair use naltrexone, or nalmefene?

Both appear in his research. His rat studies used several opioid blockers, nalmefene among them, and his writing grouped naltrexone, naloxone and nalmefene together.

In the UK, The Sinclair Method uses naltrexone. It's taken before drinking, at a time your prescriber sets. That use is outside naltrexone's UK licence, so it's off-label.

Nalmefene is a different medicine, with its own UK licence. NICE recommends it as an option to help some people with alcohol dependence cut down, and only alongside continuous psychosocial support. Whether either one is right for you is a decision for a prescriber who knows your health.

How did The Sinclair Method reach the UK?

For many people, through a book and an actor.

In 2012, a second edition of The Cure for Alcoholism by Dr Roy Eskapa was published, with a foreword by Sinclair and a new introduction by the actor Claudia Christian.

Christian used the method for her own drinking and narrated One Little Pill, a 2014 documentary about it.

That's how Matt, our co-founder, found it too. He came across Claudia Christian by accident, through YouTube autoplay... In his words: "And for the first time, someone was talking to me logically; about the brain, not morality."

What does that mean for you now?

A few honest things, from everything above.

  • Stopping isn't the only route. UK guidance says that for harmful drinking or mild dependence, without other serious health problems and with good support around you, a doctor can consider moderate drinking as the goal, unless you'd prefer to stop or there's another reason to advise stopping.

  • It's a method, not a pill. It's not the medication itself that makes the method, it's the protocol of how to take it.

  • Support was the common thread in the trials. Taking a tablet cannot change our habits. Over time, the medicine can quieten the desire... But the Friday nights, the stress, the routines built around a drink over years? That's the real work: Why support matters on The Sinclair Method.

  • It isn't for everyone. Even Sinclair wrote that some people seem to have a form of alcoholism that doesn't involve the opioid system.

The full explainer is here: What is The Sinclair Method?

...And if you want to ask your GP first, start with Can I get naltrexone from my GP or the NHS?

Common questions

Who developed The Sinclair Method?

Dr John David Sinclair, an American behavioural scientist who worked at Alko's research laboratories in Helsinki, Finland.

Is John David Sinclair the same person as David Sinclair from Harvard?

No. David A. Sinclair is an Australian-American biologist at Harvard Medical School who researches ageing. Dr John David Sinclair, the alcohol researcher, died in 2015.

When did Dr Sinclair die?

In April 2015, aged 72.

What is the alcohol deprivation effect?

It's Sinclair's 1967 finding that animals kept away from alcohol drank more once it came back. Full explainer: The alcohol deprivation effect.

Is The Sinclair Method available on the NHS?

Naltrexone is available on the NHS, usually taken daily once you've stopped drinking, to help you stay stopped. Using it The Sinclair Method way is off-label, so many NHS doctors won't prescribe it that way. See Can I get naltrexone from my GP?

Does The Sinclair Method work?

For some people, yes. Controlled trials show naltrexone has a real, moderate effect, and results vary. Here's the evidence: what the research really shows.

If you'd like support from us

Rethink Drink is a UK coaching service built around The Sinclair Method. Our programmes include a consultation with an independent prescriber, who decides whether treatment is suitable. Clinical oversight is provided by consultant psychiatrist Professor Jonathan Chick. Any prescription is dispensed by an independent partner pharmacy. Our coaches work with you, week by week, on everything around it.

And whatever happens, you can talk to someone today. Drinkline, the national alcohol helpline, is free and confidential: 0300 123 1110.

Please look after yourself

This page is here to help you understand your options. It isn't medical advice, and it can't replace a conversation with a doctor who can ask qualifying questions.

Before you change how much you drink or start any medication, speak to your GP or a prescriber.

We really hope this post helps. If you have any questions, you can contact us here.

The Rethink Drink team

Sources

  1. C Three Foundation. Why aren't doctors prescribing this medication? (on Sinclair's career: University of Cincinnati, arrival in Finland in May 1972, the Alko laboratory and its later reorganisation, his death in April aged 72). https://cthreefoundation.org/?p=608

  2. Yle (Finnish Broadcasting Company), 1 June 2015. Article on alcohol research in Finland, noting David Sinclair came to Finland in 1972 for Alko's research and died in April 2015 (in Finnish). https://yle.fi/a/20-131334

  3. New York Public Library catalogue. Sinclair, John David, 1943- (author record, birth year). https://www.nypl.org/research/research-catalog/bib/b10611087

  4. Alko. History of Alko. https://www.alko.fi/en/alko-inc/about-alko-history-of-alko

  5. Sinclair JD, Senter RJ. Increased preference for ethanol in rats following alcohol deprivation. Psychonomic Science, 1967; 8: 11 to 12. https://doi.org/10.3758/BF03330642

  6. Sinclair JD. Definitive statement by John David Sinclair, Ph.D. C Three Foundation. https://cthreefoundation.org/resources/definitive-statement-by-john-david-sinclair-ph-d

  7. Sinclair JD. Method for treating alcohol-drinking response. US Patent 4,882,335 (filed 13 June 1988, granted 21 November 1989; assignee Alko). https://patents.google.com/patent/US4882335

  8. Mitchell JM and colleagues. Alcohol consumption induces endogenous opioid release in the human orbitofrontal cortex and nucleus accumbens. Science Translational Medicine, 2012 (summary). https://neurosciencenews.com/endorphins-alcohol-brain-research-addiction

  9. Sinclair JD. Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism. Alcohol and Alcoholism, 2001; 36(1): 2 to 10. https://cthreefoundation.org/wp-content/uploads/2018/08/review_nal_2001_print_us_1.pdf

  10. Heinälä P, Alho H, Kiianmaa K, Lönnqvist J, Kuoppasalmi K, Sinclair JD. Targeted use of naltrexone without prior detoxification in the treatment of alcohol dependence: a factorial double-blind, placebo-controlled trial. Journal of Clinical Psychopharmacology, 2001; 21(3): 287 to 292. https://www.cpsp.pitt.edu/wp-content/uploads/2021/01/3-VIIH3-2001-Targeted-Use-of-Naltrexone.pdf

  11. Rösner S and colleagues. Opioid antagonists for alcohol dependence. Cochrane Database of Systematic Reviews (CD001867). https://www.cochrane.org/CD001867/alcohol-opioid-antagonists-alcohol-dependence

  12. NICE. Nalmefene for reducing alcohol consumption in people with alcohol dependence (TA325). https://www.nice.org.uk/guidance/TA325/chapter/1-guidance

  13. NICE. Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependence (CG115). https://www.nice.org.uk/guidance/cg115

  14. Simon and Schuster. The Cure for Alcoholism, by Roy Eskapa, foreword by David Sinclair (second edition, BenBella Books, 2012). https://www.simonandschuster.co.uk/books/Cure-for-Alcoholism/Roy-Eskapa/9781937856144

  15. Wikipedia. One Little Pill (2014 documentary). https://en.wikipedia.org/wiki/One_Little_Pill

  16. Wikipedia. David A. Sinclair. https://en.wikipedia.org/wiki/David_A._Sinclair

Rethink Drink

Rethink Drink

Rethink Drink is a UK coaching service for people who want to change their relationship with alcohol using The Sinclair Method. Our articles explain the method, naltrexone and drinking less in plain English, written by our coaches and checked against the evidence. Rethink Drink is run by Matt Brindley and Bruce Rose.

LinkedIn logo icon
Instagram logo icon
Youtube logo icon
Back to Blog

The Sunday Reset

Every Sunday, we share a 2-minute insight into the logic of the Sinclair Method.

Join thousands of others for our weekly newsletter and change how you see the problem,

because when you change the way you look at things, the things you look at change.

… There’s a reason we’re called Rethink Drink!

Rethink Drink Footer Logo

Copyright Rethink Drink Ltd 2023-2026 | Company Registration Number 14619896

The Sinclair Method | Privacy Policy | FAQ | Login | Free UK Alcohol Units Calculator | What is the Sinclair Method?